Stryker
American multinational medical technology company that develops and manufactures orthopedic implants, surgical equipment, and neurotechnology products, with in-house additive manufacturing capability for 3D-printed porous metal implants.
- CEO / Founder
- Kevin A. Lobo
- Team Size
- 10000+
- Stage
- Public
- Latest Round
- IPO
Technology & Products
Key Products
Triathlon Tritanium Tibial Baseplate and Patella (3D-printed cementless knee); Tritanium PL and TL Curved Posterior Lumbar Cages (spine); Tritanium Anterior Cervical Cages; Mako robotic-arm assisted surgery system; TPX HD power tool; Prostep MIS Lapidus bunion system; Neptune Waste Management System; acute care, emergency care, and surgical equipment portfolio
Technological Advantage
Proprietary AMagine platform for additive manufacturing; Tritanium In-Growth Technology (porous titanium designed for bone in-growth); SOMA (Stryker Orthopaedics Modeling & Analytics) evidence-based design database; vertically integrated AM supply chain with dedicated 156,000 sq ft facility at Anngrove, Cork, Ireland.
Differentiation
Value Proposition
Proprietary additive manufacturing (AMagine Institute) enables production of porous titanium implants (Tritanium technology) that mimic cancellous bone structure for biologic fixation, with over 2 million 3D-printed implants delivered since 2013.
How They Differentiate
Stryker is differentiated by its two-decade head start in medical AM (since 2001), full vertical integration of AM design, development, and production through the AMagine Institute, proprietary Tritanium porous titanium technology, and the scale of over 2 million 3D-printed implants delivered.
Market & Competition
Target Customers
Hospitals, ambulatory surgery centers, orthopedic surgeons, neurosurgeons, and healthcare systems worldwide
Industry Verticals
Orthopedic surgery (joint replacement, trauma, spine); Neurotechnology; Medical and surgical equipment; Emergency medical services
Competitors
Johnson & Johnson (DePuy Synthes); Zimmer Biomet Holdings Inc.; Medtronic plc
Growth & Milestones
Growth Metrics
$22.59B revenue (2024); $3.689B operating income (2024); ~$120B market cap (2026); 53,000 employees; Fortune 500 rank #195
Major Milestones
1941: Founded as The Orthopedic Frame Company by Dr. Homer Stryker; 1964: Renamed Stryker Corporation; 1979: IPO on NYSE (SYK); 2001: Began additive manufacturing R&D; 2013: First Tritanium 3D-printed implants commercialized; 2017: Opened AMagine Institute in Cork, Ireland; 2022: Expanded Anngrove facility (156,000 sq ft) with capacity for 600 jobs; 2024: Over 2 million 3D-printed Tritanium implants delivered since 2013
Notable Customers
Over 150 million patients treated annually; products used in 75+ countries; hospital systems and surgical centers globally; U.S. Department of Veterans Affairs and military health system